All posts

Thousands of men with prostate cancer in England are set to benefit from a new, highly targeted form of radiotherapy that can significantly reduce treatment time while maintaining effective cancer care. NHS England has announced that eligible men with early-stage, localised prostate cancer will now be offered stereotactic ablative radiotherapy (SABR), a pioneering treatment that delivers high-dose radiotherapy directly to tumours with exceptional precision. Prostate cancer is